Acellular Dermal Matrices Market Report 2026

Acellular Dermal Matrices Market Overview

• Acellular Dermal Matrices market size has reached to $1.61 billion in 2025 • Expected to grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Increasing Incidences Of Chronic Wounds Driving The Growth Of The Market Due To Rising Diabetes-related Complications • Market Trend: Improving Surgical Versatility With Dual-Sided Grafts For Soft Tissue Reconstruction • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Acellular Dermal Matrices Market?

Acellular dermal matrices (ADMs) are natural materials made from skin tissue that have been processed to remove all cells. These materials are used in surgeries to help repair or replace damaged tissue. They act as a scaffold that encourages new tissue to grow and heal. ADMs are commonly used in procedures such as breast reconstruction or wound healing to support and regenerate the skin and soft tissues. The main product types of acellular dermal matrices are human acellular dermal matrices, porcine acellular dermal matrices, and other source acellular dermal matrices. Human acellular dermal matrices (HADMs) are biomaterials derived from donated human skin that have had all cellular components removed, leaving behind a collagen-rich scaffold used to support tissue regeneration in reconstructive and surgical procedures. These products are distributed through channels including direct sales, online sales, and distributor sales. They are used in various applications such as breast reconstruction, dental surgery, orthopedic surgery, wound care, and other medical procedures, catering to end users, including hospitals, ambulatory surgical centers, specialty clinics, and research laboratories.

What Is The Acellular Dermal Matrices Market Growth Forecast?

The acellular dermal matrices market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine solutions, rising adoption of advanced wound care products, expansion of minimally invasive surgical procedures, growing focus on faster healing outcomes, increasing clinical acceptance of biologic implants. Major trends in the forecast period include increasing adoption of adms in reconstructive surgeries, rising use of biologic scaffolds in wound care, growing preference for ready-to-use dermal matrices, expansion of adm applications in orthopedic procedures, enhanced focus on biocompatibility and healing outcomes.

What Is The Driver Of The Acellular Dermal Matrices Market?

The increasing incidences of chronic wounds are expected to propel the growth of the acellular dermal matrices market going forward. Chronic wounds are cuts or sores that take a long time to heal or don’t heal at all. They often come back and may need special care to get better. Chronic wounds are increasing as more people now have diabetes. Diabetes can reduce blood flow and damage nerves, which makes it harder for the body to heal wounds. As a result, even small cuts can turn into serious, long-lasting wounds. Acellular dermal matrices help reduce the incidence of chronic wounds by providing a supportive layer that encourages natural skin repair and faster healing. For instance, in July 2023, according to OSF HealthCare, a US-based nonprofit healthcare system, 6.7 million people in the US currently live with chronic wounds, which is expected to increase by 2% per year over the next decade. Therefore, the increasing incidences of chronic wounds are driving the growth of the acellular dermal matrices industry.

Key Players In The Global Acellular Dermal Matrices Market

Major companies operating in the acellular dermal matrices market are Stryker Corporation, Smith & Nephew plc, ConvaTec Group plc, Integra LifeSciences Corporation, Gunze Limited, MTF Biologics, Organogenesis Inc., RTI Surgical Holdings Inc., LifeNet Health, HANS BIOMED, PolyNovo Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, CG Bio Inc., Meccellis Biotech, Aziyo Biologics Inc., MiMedx Group Inc., Axogen Inc., AlloSource, Kerecis Ltd.

Global Acellular Dermal Matrices Market Trends and Insights

Major companies operating in the acellular dermal matrices market are focusing on developing innovative products such as dual-sided acellular dermal matrices to enhance surgical versatility and integration efficiency. Dual-sided acellular dermal matrices are specialized grafts designed with surfaces suitable for multi-directional implantation, reducing handling complexity and improving surgical outcomes. For instance, in May 2023, AlloSource, a US-based nonprofit organization specializing in providing allografts derived from human tissue to support medical procedures, launched AlloMend Duo Acellular Dermal Matrix (ADM). This innovative solution is designed for soft tissue reconstruction, offering surgeons a reliable tool for repairing and reconstructing soft tissue defects with long-term structural support. The deep reticular dermal allograft integrates seamlessly with surrounding tissue, providing a scaffold that promotes cell repopulation and regeneration of natural host tissues.

What Are Latest Mergers And Acquisitions In The Acellular Dermal Matrices Market?

In March 2023, Aziyo Biologics, a US-based regenerative medicine company, partnered with Sientra Inc. to enhance women's access to biologic solutions for soft tissue reconstruction. The collaboration focuses on increasing the availability of SimpliDerm, an acellular dermal matrix, for use in soft tissue reconstruction procedures. This initiative aims to expand access to biologic products for women undergoing breast reconstruction. Sientra Inc. is a US-based medical aesthetics company that specializes in making silicone breast implants and other products used in cosmetic and reconstructive breast surgery.

What Defines the Acellular Dermal Matrices Market?

The acellular dermal matrices market includes sales of xenogeneic acellular dermal matrices, collagen-based acellular dermal matrices, bi-layered acellular dermal matrices, and dermal substitute products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acellular Dermal Matrices Market Report 2026?

The acellular dermal matrices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acellular dermal matrices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.